Mari Shinohara

Prof. Mari Shinohara

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MIMakoto Inoue
Makoto Inoue
KWKristi L. Williams
Kristi L. Williams
MGMichael D. Gunn
Michael D. Gunn
MSMari Shinohara
Mari Shinohara
The NLRP3 inflammasome is a multiprotein complex consisting of three kinds of proteins, NLRP3, ASC, and pro-caspase-1, and plays a role in sensing pathogens and danger signals in the innate immune system. The NLRP3 inflammasome is thought to be involved in the development of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). However, the mechanism by which the NLRP3 inflammasome induces EAE is not clear. In this study, we found that the NLRP3 inflammasome played a critical role in inducing T-helper cell migration into the CNS. To gain migratory ability, CD4 + T cells need to be primed by NLRP3 inflammasome-sufficient antigen-presenting cells to up-regulate chemotaxis-related proteins, such as osteopontin, CCR2, and CXCR6. In the presence of the NLRP3 inflammasome, dendritic cells and macrophages also induce chemotactic ability and up-regulate chemotaxis-related proteins, such as α4β1 integrin, CCL7, CCL8, and CXCL16. On the other hand, reduced Th17 cell population size in immunized Nlrp3 −/− and Asc −/− mice is not a determinative factor for their resistance to EAE. As currently applied in clinical interventions of MS, targeting immune cell migration molecules may be an effective approach in treating MS accompanied by NLRP3 inflammasome activation.

22 May 2012 in Science Signaling
Verified
Journal Article
Closed access
PDF file
MIMakoto Inoue
Makoto Inoue
KWKristi L. Williams
Kristi L. Williams
TOTimothy Oliver
Timothy Oliver
PVPeter Vandenabeele
Peter Vandenabeele
JRJayant V. Rajan
Jayant V. Rajan
MSMari Shinohara
Mari Shinohara
Characterization of an animal model may explain why not all patients with multiple sclerosis respond to interferon-β.

7 December 2010 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
MIMakoto Inoue
Makoto Inoue
MSMari Shinohara
Mari Shinohara

6 January 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
YYYasuhito Yahara
Yasuhito Yahara
TBTomasa Barrientos
Tomasa Barrientos
YTYuning J. Tang
Yuning J. Tang
VPVijitha Puviindran
Vijitha Puviindran
PNPuviindran Nadesan
Puviindran Nadesan
BABenjamin A. Alman
Benjamin A. Alman

20 February 2017 in Brain Pathology
Verified
Journal Article
Closed access
PDF file
WBWilliam Barclay
William Barclay
MSMari Shinohara
Mari Shinohara

16 December 2022 in International Immunology
Verified
Journal Article
Open access
PDF file
ELElliot Yi-Hsin Lin
Elliot Yi-Hsin Lin
WXWen Xi
Wen Xi
NANupur Aggarwal
Nupur Aggarwal
MSMari Shinohara
Mari Shinohara
Osteopontin (OPN) is a multifunctional protein, initially identified in osteosarcoma cells with its role of mediating osteoblast adhesion. Later studies revealed that OPN is associated with many inflammatory conditions caused by infections, allergic responses, autoimmunity and tissue damage. Many cell types in the peripheral immune system express OPN with various functions, which could be beneficial or detrimental. Also, more recent studies demonstrated that OPN is highly expressed in the central nervous system (CNS), particularly in microglia during CNS diseases and development. However, understanding of mechanisms underlying OPN’s functions in the CNS is still limited. In this review, we focus on peripheral myeloid cells and CNS-resident cells to discuss the expression and functions of OPN.